UBS Group’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $310K | Sell |
|
|||||
|
2025
Q1 | $478K | Sell |
|
|||||
|
2024
Q4 | $1.09M | Buy |
|
|||||
|
2024
Q3 | $301K | Buy |
|
|||||
|
2024
Q2 | $208K | Sell |
|
|||||
|
2024
Q1 | $373K | Buy |
|
|||||
|
2023
Q4 | $344K | Buy |
|
|||||
|
2023
Q3 | $128K | Sell |
|
|||||
|
2023
Q2 | $718K | Buy |
|
|||||
|
2023
Q1 | $302K | Sell |
|
|||||
|
2022
Q4 | $281K | Buy |
|
|||||
|
2022
Q3 | $24K | Sell |
|
|||||
|
2022
Q2 | $47K | Sell |
|
|||||
|
2022
Q1 | $117K | Buy |
|
|||||
|
2021
Q4 | $113K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $0 | Sell |
|
|||||
|
2021
Q1 | $43K | Buy |
|
|||||
|
2020
Q4 | $26K | Sell |
|
|||||
|
2020
Q3 | $29K | Sell |
|
|||||
|
2020
Q2 | $59K | Sell |
|
|||||
|
2020
Q1 | $99K | Sell |
|
|||||
|
2019
Q4 | $147K | Buy |
|
|||||
|
2019
Q3 | $102K | Buy |
|
|||||
|
2019
Q2 | $87K | Buy |
|
|||||
|
2019
Q1 | $43K | Sell |
|
|||||
|
2018
Q4 | $38K | Sell |
|
|||||
|
2018
Q3 | $69K | Sell |
|
|||||
|
2018
Q2 | $42K | Buy |
|
|||||
|
2018
Q1 | $25K | Buy |
|
|||||
|
2017
Q4 | $26K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $35K | Buy |
|
|||||
|
2017
Q1 | $14K | Sell |
|
|||||
|
2016
Q4 | $26K | Buy |
|
|||||
|
2016
Q3 | $35K | Buy |
|
|||||
|
2016
Q2 | $9K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $673K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $15K | Buy |
|